Christopher Mirabelli

Insider Reports History

Entity
Individual
Location
55 Cambridge Parkway, Suite 301, Cambridge, MA
Signature
/s/ Douglas E. Onsi, as Attorney-in-Fact for Christopher Mirabelli
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Mirabelli:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LEAP THERAPEUTICS, INC. Chairman of the Board, Director Common Stock 678K $1.91M $2.82 Nov 13, 2024 Indirect
LEAP THERAPEUTICS, INC. Chairman of the Board, Director Common Stock 5.09K $14.3K $2.82 Nov 13, 2024 Direct
LEAP THERAPEUTICS, INC. Chairman of the Board, Director Restricted Stock Units 0 $0 $2.85 Jan 26, 2024 Direct
LEAP THERAPEUTICS, INC. Chairman of the Board, Director Stock Option (Right to Buy) 85K Oct 2, 2024 Direct
LEAP THERAPEUTICS, INC. Chairman of the Board, Director Warrant (Right to Buy) 0 Nov 13, 2024 Indirect

Insider Reports Filed by Christopher Mirabelli

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LPTX LEAP THERAPEUTICS, INC. Nov 13, 2024 2 $6.02K 4 Nov 15, 2024 Chairman of the Board, Director
LPTX LEAP THERAPEUTICS, INC. Oct 2, 2024 1 $0 4 Oct 4, 2024 Director
LPTX LEAP THERAPEUTICS, INC. Jan 29, 2024 1 $0 4 Jan 31, 2024 Chairman of the Board, Director
LPTX LEAP THERAPEUTICS, INC. Jan 26, 2024 2 $0 4 Jan 30, 2024 Chairman of the Board, Director
LPTX LEAP THERAPEUTICS, INC. Aug 23, 2023 1 $0 4 Aug 25, 2023 Chairman of the Board, Director
LPTX LEAP THERAPEUTICS, INC. Mar 31, 2023 1 $0 4 Apr 4, 2023 Director
LPTX LEAP THERAPEUTICS, INC. Sep 1, 2022 1 $0 4 Sep 2, 2022 Director
LPTX LEAP THERAPEUTICS, INC. Jan 31, 2022 1 $0 4 Feb 2, 2022 Director, Chairman of the Board, 10%+ Owner
LPTX LEAP THERAPEUTICS, INC. May 26, 2021 1 $0 4 May 28, 2021 Director, 10%+ Owner